Kraig Biocraft Laboratories, Inc., a development stage company, develops protein based fiber, using recombinant DNA technology, for commercial applications in the textile and specialty fiber industries. The company uses genetic engineering technologies to develop fibers with greater strength, resiliency and flexibility for use in its target markets, such as the textile, specialty fiber and technical textile industries. Under the Exclusive License Agreement with The University of Wyoming, the company has obtained certain exclusive rights to use numerous genetic sequences which are the subject of U.S. patents. In 2011, the company entered into a license agreement with the University of Notre Dame. Under the agreement, the company received exclusive and non-exclusive rights to certain spider silk technologies, including commercial rights with the right to sublicense such intellectual property. Markets The market for technical textiles can be defined as consisting of: medical textiles; geotextiles; textiles used in defense and military; safe and protective clothing; filtration textiles; textiles used in transportation; textiles used in buildings; composites with textile structure; and functional and sportive textiles. Significant Events In October 2013, Kraig Biocraft Laboratories, Inc. and Warwick Mills, Inc. announced that they have signed a collaborative development agreement concerning the development and commercialization of advanced textiles utilizing Kraig's Monster Silk recombinant spider silk technology. History Kraig Biocraft Laboratories, Inc. was founded in 2006.
kraig biocraft laboratories
120 North Washington Square
Lansing, MI 48933
|No competitor information is available for KBLB.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact KRAIG BIOCRAFT LABORATORIES, please visit www.kraiglabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.